China Shanghai International Pharmaceutical Raw Materials ExhibitionAPI China

The China International API Exhibition (API China), the longest-running trade show in China’s pharmaceutical sector, was first launched in 1968. Its exhibits encompass not only more than 50,000 APIs across 24 major categories but also all excipients, functional ingredients, primary and secondary packaging materials, as well as production and testing equipment required for the manufacture of pharmaceuticals and health products.

With the ongoing implementation of generic drug consistency evaluations and the introduction of a joint review-and-approval policy for APIs, excipients, and packaging materials, pharmaceutical companies are increasingly taking responsibility for product quality, thereby significantly boosting the proactive engagement of API manufacturers.

The China International API Exhibition (API China)has become an efficient, one-stop industry platform for tens of thousands of domestic and international pharmaceutical and health‑product manufacturers, offering an unparalleled opportunity to gain a comprehensive understanding of emerging trends in China’s pharmaceutical and health‑product sectors, forge valuable industry connections, and uncover new business prospects. (Copyright of this content belongs to Juzhan; unauthorized reproduction is prohibited.)

The China International API Exhibition (API China)is poised to unleash fresh momentum as the joint review-and-approval system takes effect. Leading Chinese pharmaceutical giants—including Sinopharm Group, Tianjin Pharmaceutical Group, Shanghai Pharmaceuticals Holding Co., Ltd., Qilu Pharmaceutical, Northeast Pharmaceutical Group, Shandong Xinhua Pharmaceutical, Lizhu Group, Huahai Pharmaceutical, Haizheng Pharmaceutical, Chuanuo Pharmaceutical, Hengxin Pharmaceutical, Disheng Pharmaceutical, and Erkang Pharmaceutical—will gather to showcase their time‑tested flagship products alongside cutting‑edge innovations developed through the latest R&D efforts.